Abeona Therapeutics ABEO
NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Abeona Therapeutics (ABEO) FCF Margin Growth (5y) (2016 - 2025)

Analysis

Abeona Therapeutics (ABEO) FCF Margin Growth (5y) (2016 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Abeona Therapeutics 342.29 Mn 195.46 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -29,774.00
Jun 30, 2023 421,359.00
Dec 31, 2022 -1.72 Mn
Jun 30, 2022 139,916.00
Mar 31, 2022 -72,430.00
Dec 31, 2020 140,756.00
Sep 30, 2020 73,412.00
Dec 31, 2018 -121,624.00
Sep 30, 2018 -14,074.00
Jun 30, 2018 -488,028.00
Mar 31, 2018 -139,998.00
Dec 31, 2017 -368,219.00
Sep 30, 2017 -306,886.00
Jun 30, 2017 -218,785.00
Mar 31, 2017 -312,910.00
Dec 31, 2016 -85,340.00
Sep 30, 2016 -196,038.00
Jun 30, 2016 -29,629.00
Mar 31, 2016 -59,457.00